<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2795-5001</journal-id>
<journal-title><![CDATA[Portuguese Journal of Dermatology and Venereology]]></journal-title>
<abbrev-journal-title><![CDATA[Port J Dermatol Venereol.]]></abbrev-journal-title>
<issn>2795-5001</issn>
<publisher>
<publisher-name><![CDATA[Permanyer Publications]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2795-50012025000200113</article-id>
<article-id pub-id-type="doi">10.24875/pjdv.25000003</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Kaposi&#8217;s sarcoma: a 15-year retrospective study in a Portuguese hospital]]></article-title>
<article-title xml:lang="pt"><![CDATA[Sarcoma de Kaposi: um estudo retrospetivo de 15 anos num hospital português]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Leme]]></surname>
<given-names><![CDATA[Hugo J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Magarreiro-Silva]]></surname>
<given-names><![CDATA[António]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gouveia]]></surname>
<given-names><![CDATA[Ana I.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[João]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Garcia de Orta Serviço de Dermatologia ]]></institution>
<addr-line><![CDATA[Almada ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>83</volume>
<numero>2</numero>
<fpage>113</fpage>
<lpage>118</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2795-50012025000200113&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2795-50012025000200113&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2795-50012025000200113&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objectives: To characterize the demographic and clinical aspects and describe the therapeutic approaches used in patients with Kaposi&#8217;s sarcoma at Hospital Garcia de Orta.  Methods: A retrospective, descriptive, and observational study that included patients with a histological diagnosis of Kaposi&#8217;s sarcoma at Hospital Garcia de Orta between March 2009 and March 2024.  Results: A total of 55 patients were included, 43 males and 12 females, with an average age at diagnosis of 63.55 years. The majority of patients (67.3%) had lesions in a single anatomical location, mainly in the lower limbs. The most frequently observed subtype was classic (38.2%), followed by epidemic (36.4%), endemic (23.6%) and, finally, iatrogenic (1.8%). The time from symptom onset to diagnosis was longer in the endemic subtype (40.78 months). The epidemic subtype had the highest proportion of patients with systemic involvement (55%). The majority of patients (56.4%) underwent monotherapy. There was heterogeneity in the therapeutic modalities used.  Conclusion: This study highlights there is still a considerable delay in diagnosis, underlines the evolving demographic characteristics of the disease, and emphasizes the importance of adapting treatment to the subtype and extent of the disease.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivos: Caraterizar os aspetos demográficos e clínicos, bem como descrever as abordagens terapêuticas utilizadas nos doentes diagnosticados com sarcoma de Kaposi no Hospital Garcia de Orta.  Métodos: Estudo retrospetivo, descritivo e observacional que incluiu os doentes com diagnóstico histológico de sarcoma de Kaposi no Hospital Garcia de Orta entre março de 2009 e março de 2024.  Resultados: Foram incluídos 55 doentes, 43 do sexo masculino e 12 do sexo feminino, com uma média de idades ao diagnóstico de 63.55 anos. A maioria dos doentes (67.3%) tinha lesões numa única localização anatómica, principalmente nos membros inferiores. O subtipo mais frequentemente observado foi o clássico (38.2%), seguido do epidémico (36.4%), do endémico (23.6%) e, finalmente, o iatrogénico (1.8%). O tempo desde o início dos sintomas até ao estabelecimento do diagnóstico foi superior no subtipo endémico (40.78 meses), com uma média geral de 18,3 meses. O subtipo epidémico tem a maior proporção de doentes com envolvimento sistémico (55%). A maioria dos doentes (56.4%) foi submetida a monoterapia. Observou-se uma heterogeneidade nas modalidades terapêuticas utilizadas.  Conclusão: Este estudo revela que ainda existe um atraso considerável no diagnóstico, salienta a evolução das caraterísticas demográficas da doença e realçam a importância de adaptar o tratamento ao subtipo e à extensão da doença.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Kaposi&#8217;s sarcoma]]></kwd>
<kwd lng="en"><![CDATA[Classification]]></kwd>
<kwd lng="en"><![CDATA[HIV]]></kwd>
<kwd lng="en"><![CDATA[Human herpesvirus 8]]></kwd>
<kwd lng="pt"><![CDATA[Sarcoma de Kaposi]]></kwd>
<kwd lng="pt"><![CDATA[Classificação]]></kwd>
<kwd lng="pt"><![CDATA[VIH]]></kwd>
<kwd lng="pt"><![CDATA[Herpesvírus humano 8]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vangipuram]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tyring]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Kaposi sarcoma:review and description of the nonepidemic variant]]></article-title>
<source><![CDATA[Int J Dermatol]]></source>
<year>2019</year>
<volume>58</volume>
<page-range>538-42</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lebbe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Garbe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stratigos]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Harwood]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Peris]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Marmol]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and treatment of Kaposi's sarcoma:European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)]]></article-title>
<source><![CDATA[Eur J Cancer]]></source>
<year>2019</year>
<volume>114</volume>
<page-range>117-27</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Motlhale]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sitas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bradshaw]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Singini]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[De Villiers]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Kaposi's sarcoma in sub-Saharan Africa]]></article-title>
<source><![CDATA[Cancer Epidemiol]]></source>
<year>2022</year>
<volume>78</volume>
<page-range>102167</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Marino]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cozzolino]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Del Fiore]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Nerjaku]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Finotto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Kaposi's sarcoma:evaluation of clinical features, treatment outcomes, and prognosis in a single-center retrospective case series]]></article-title>
<source><![CDATA[Cancers (Basel)]]></source>
<year>2024</year>
<volume>16</volume>
<page-range>691</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Resende]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Henriques]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Calima]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vale]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sarcoma de Kaposi - revisão clínico-patológica]]></article-title>
<source><![CDATA[Rev Soc Port Dermatol Venereol]]></source>
<year>2014</year>
<volume>72</volume>
<page-range>471-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cahoon]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[Linet]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Pawlish]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Engels]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Pfeiffer]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of Kaposi sarcoma after solid organ transplantation in the United States]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>2018</year>
<volume>143</volume>
<page-range>2741-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ngalamika]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Sub-Saharan Africa perspective of HIV-associated Kaposi's sarcoma incidence, prevalence, clinical presentations, and treatment outcomes]]></article-title>
<source><![CDATA[Am J Biomed Sci Res]]></source>
<year>2020</year>
<volume>10</volume>
<page-range>540-2</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Facciolà]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rullo]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
<name>
<surname><![CDATA[Ceccarelli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aleo]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[Di Rosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pinzone]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2017</year>
<volume>21</volume>
<page-range>5868-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Denaro]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Indini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Brambilla]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Marzano]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
<name>
<surname><![CDATA[Garrone]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Tourlaki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management and future therapeutic perspectives of classic Kaposi's sarcoma:an evidence-based review]]></article-title>
<source><![CDATA[Onco Targets Ther]]></source>
<year>2024</year>
<volume>17</volume>
<page-range>961-76</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
